1.
Santos AMC, Kotsanis A, Cunningham L, Penfold SN. Estimating the second primary cancer risk due to proton therapy compared to hybrid IMRT for left sided breast cancer. AO [Internet]. 2021 Apr. 3 [cited 2026 Jul. 26];60(3):300-4. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/21416